Mehul Desai
机构：Enable Ireland · ORCID：0000-0003-3489-1967
发表论文 65 篇 · 总被引 13514 次 · h-index 32
代表论文
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (2017 · New England Journal of Medicine · 被引 7838)
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events (2017 · Circulation · 被引 505)
- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus (2018 · Circulation · 被引 489)
- Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function (2018 · Circulation · 被引 254)
- Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes (2017 · Journal of the American College of Cardiology · 被引 219)
- Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( CANVAS‐R ): A randomized, placebo‐controlled trial (2017 · Diabetes Obesity and Metabolism · 被引 173)